MercadoLibre (MELI) surged late Thursday after the Latin American e-commerce and payments giant that blew past second-quarter estimates, with net profit more than doubling from the...
In a welcome move, Gold Field (GFI) stock saw its Relative Strength Rating rise from 69 to 75 on Thursday. ↑ X What Stocks Should You...
Regeneron stock edged higher Thursday despite mixed results for its bread-and-butter eye-disease treatment franchise, Eylea. ↑ X NOW PLAYING How To Buy Stocks: Cup With Handle...
Who knew that having naturally curly hair could lead to business success? Not Alli Webb, who, in 2010, co-founded Drybar, a chain of salons that provided...
Medical aesthetics company Evolus (EOLS) notched its first-ever profit late Wednesday, two quarters ahead of expectations. ↑ X NOW PLAYING Biotech Stocks Are Shooting Higher. Here’s...
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. SentinelOne (S) stock just hit that mark, with a...
Amazed by Nvidia‘s (NVDA) expected earnings growth this year? Join the club. But what about the fast-growing S&P 500 stocks, though, that everyone’s missing out on?...
Medpace (MEDP) stock crumbled late Monday on a “shocking bookings miss” and after the clinical research organization slashed its 2024 sales guidance by $25 million at...
Top growth stocks to buy and watch this week on IBD’s Sector Leaders screen include a player in financial stocks, Axos Financial (AX), and India-based MakeMyTrip...
The Dow Jones Industrial Average hit an all-time high on Monday. And analysts think you haven’t seen the end of the gains — if you look...
Among top medical stocks to watch on the IBD Sector Leaders, Ozempic maker Novo Nordisk (NVO) continues to trade within a buy zone and to exhibit tight...
Stock prices anticipate the future. But such wishful thinking is reaching extreme levels in some S&P 500 stocks. ↑ X NOW PLAYING Beating The Market: How...